Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:27 PM
Ignite Modification Date:
2025-12-24 @ 2:27 PM
NCT ID:
NCT02608359
Eligibility Criteria:
Inclusion Criteria:
* Participants with established diagnosis of metastatic castration-resistant prostate carcinoma
* Being newly initiated on Zytiga treatment (abiraterone acetate tablets 250 mg) based on independent clinical judgment of treating physicians as per locally approved prescribing information
* Willing to provide written informed consent indicating that they understand the purpose and are willing to participate in the post-marketing surveillance (PMS)
Exclusion Criteria:
* Participants who are not eligible to receive Zytiga as per the locally approved prescribing information
* Participants participating or planning to participate in any interventional drug trial during the course of this PMS
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT02608359
Study Brief:
Protocol Section:
NCT02608359